2-[3-(4-chlorophenyl)-5-sulfanylidene-4,5-dihydro-1H-1,2,4-triazol-4-yl]acetic acid, 97%, 250mg

(R)-Azetidine-2-carboxylic acid, 95.0%, 25g

2-methyl-4-(4-piperidinyl)pyrimidine dihydrochloride, 95.0%, 250mg

Methyl 5-Hexenoate>98.0%(GC)25g

14-(4-Nitrophenoxy)-3,6,9,12-tetraoxatetradecan-1-ol, 98%, 100mg

5-Bromo-2-fluoro-m-xylene, 97.0%, 25g

[2-(4-fluorophenoxy)ethyl]amine methanesulfonate, 95.0%, 10g

((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate, 97%, 5g

Diethylene Glycol Monomethyl Ether Methacrylate (stabilized with MEHQ)>97.0%(GC)25mL

(1H-1,2,4-triazol-5-ylmethyl)amine hydrochloride, 95.0%, 1g

Methyl 4'-formyl-[1,1'-biphenyl]-2-carboxylate, 95.0%, 5g

tert-Butyl (4aS,9bR)-8-fluoro-1,3,4,4a,5,9b-hexahydro-2H-pyrido[4,3-b]indole-2-carboxylate, 95%, 2g

2-(3,3-difluoropiperidin-1-yl)ethan-1-ol hydrochloride, 95.0%, 500mg